These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 12153969

  • 1. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
    Suri R, Marshall LJ, Wallis C, Metcalfe C, Bush A, Shute JK.
    Am J Respir Crit Care Med; 2002 Aug 01; 166(3):352-5. PubMed ID: 12153969
    [Abstract] [Full Text] [Related]

  • 2. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R, Metcalfe C, Wallis C, Bush A.
    Pediatr Pulmonol; 2004 Apr 01; 37(4):305-10. PubMed ID: 15022126
    [Abstract] [Full Text] [Related]

  • 3. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
    Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C.
    Lancet; 2001 Oct 20; 358(9290):1316-21. PubMed ID: 11684212
    [Abstract] [Full Text] [Related]

  • 4. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M, Dasgupta B, Tomkiewicz RP, Brown NE.
    Am J Respir Crit Care Med; 1997 Jul 20; 156(1):173-7. PubMed ID: 9230743
    [Abstract] [Full Text] [Related]

  • 5. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G, Hoffjan S, Mosler K, Schuster A.
    Lung; 2001 Jul 20; 179(3):185-94. PubMed ID: 11891608
    [Abstract] [Full Text] [Related]

  • 6. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.
    Suri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, Bush A.
    Thorax; 2002 Oct 20; 57(10):841-6. PubMed ID: 12324668
    [Abstract] [Full Text] [Related]

  • 7. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 8. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
    Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F, Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group.
    Am J Respir Crit Care Med; 2004 Mar 15; 169(6):719-25. PubMed ID: 14684561
    [Abstract] [Full Text] [Related]

  • 9. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.
    Shah PL, Scott SF, Knight RA, Hodson ME.
    Eur Respir J; 1996 Mar 15; 9(3):531-4. PubMed ID: 8730015
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human deoxyribonuclease for cystic fibrosis.
    Jones AP, Wallis CE.
    Cochrane Database Syst Rev; 2003 Mar 15; (3):CD001127. PubMed ID: 12917899
    [Abstract] [Full Text] [Related]

  • 11. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL, Gibson PG, Carty K, Cai Y, Francis JL.
    Pediatr Pulmonol; 1998 Aug 15; 26(2):97-100. PubMed ID: 9727759
    [Abstract] [Full Text] [Related]

  • 12. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ, Le Maitre C, Romero L, Steward R, Button BM, Thompson BR, Holland AE.
    Respirology; 2017 Aug 15; 22(6):1084-1092. PubMed ID: 28397992
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R, de Jongste JC, Merkus PJ.
    Pediatr Pulmonol; 2007 Nov 15; 42(11):989-1001. PubMed ID: 17902149
    [Abstract] [Full Text] [Related]

  • 14. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.
    Pediatr Pulmonol; 1996 Feb 15; 21(2):77-83. PubMed ID: 8882210
    [Abstract] [Full Text] [Related]

  • 15. Clinical trials of recombinant human DNase in cystic fibrosis patients.
    Aitken ML.
    Monaldi Arch Chest Dis; 1993 Dec 15; 48(6):653-6. PubMed ID: 8124306
    [Abstract] [Full Text] [Related]

  • 16. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
    von der Schulenburg JM, Greiner W, von der Hardt H.
    Med Klin (Munich); 1995 Apr 15; 90(4):220-4. PubMed ID: 7776934
    [Abstract] [Full Text] [Related]

  • 17. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
    Dasgupta B, King M.
    Pediatr Pulmonol; 1996 Sep 15; 22(3):161-6. PubMed ID: 8893254
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R, Wallis C, Bush A, Thompson S, Normand C, Flather M, Grieve R, Metcalfe C, Lees B.
    Health Technol Assess; 2002 Sep 15; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract] [Full Text] [Related]

  • 19. Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview.
    Hodson ME.
    Respiration; 1995 Sep 15; 62 Suppl 1():29-32. PubMed ID: 7792438
    [Abstract] [Full Text] [Related]

  • 20. Safety and use of sputum induction in children with cystic fibrosis.
    Suri R, Marshall LJ, Wallis C, Metcalfe C, Shute JK, Bush A.
    Pediatr Pulmonol; 2003 Apr 15; 35(4):309-13. PubMed ID: 12629630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.